🇺🇸
United States · US · US:55150-232_a193830a-dc25-412a-b047-d2fa77d9dbbc
FONDAPARINUX SODIUM
In shortageOrange BookUNIISPLATC B01AX05
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerEugia US LLC
CountryUS (United States)
ATC codeB01AX05
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1155150232022 SYRINGE, GLASS in 1 CARTON (55150-232-02) / .6 mL in 1 SYRINGE, GLASS (55150-232-00)
- ndc11551502321010 SYRINGE, GLASS in 1 CARTON (55150-232-10) / .6 mL in 1 SYRINGE, GLASS (55150-232-00)
Annotations
UNII (FDA Substance ID)
X0Q6N9USOZ
FONDAPARINUX SODIUM
RxCUI 322154
Orange Book
A206918
APAPAPAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Fondaparinux Sodium Injection
Raw payload (JSON)
{
"unii": {
"unii": "X0Q6N9USOZ",
"rxcui": "322154",
"inchikey": "XEKSTYNIJLDDAZ-JASSWCPGSA-D",
"display_name": "FONDAPARINUX SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"dffbf7c9-495e-4a33-ac76-57b52f014fc2": {
"match": "brand_token",
"title": "FONDAPARINUX SODIUM INJECTION, SOLUTION [ZYDUS PHARMACEUTICALS (USA) INC.]",
"spl_version": "20",
"published_date": "2025-11-17"
}
},
"productid": "55150-232_a193830a-dc25-412a-b047-d2fa77d9dbbc",
"productndc": "55150-232",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "206918",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "2.5MG/0.5ML (2.5MG/0.5ML)",
"product_no": "001",
"approval_date": "Dec 26, 2017"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "5MG/0.4ML (5MG/0.4ML)",
"product_no": "002",
"approval_date": "Dec 26, 2017"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "7.5MG/0.6ML (7.5MG/0.6ML)",
"product_no": "003",
"approval_date": "Dec 26, 2017"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "10MG/0.8ML (10MG/0.8ML)",
"product_no": "004",
"approval_date": "Dec 26, 2017"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "FONDAPARINUX SODIUM",
"shortage_reason": "Fondaparinux Sodium Injection",
"shortage_status": "current",
"proprietary_name": "FONDAPARINUX SODIUM",
"active_ingred_unit": "mg/.6mL",
"application_number": "ANDA206918",
"marketing_category": "ANDA",
"nonproprietary_name": "FONDAPARINUX SODIUM",
"start_marketing_date": "20171226",
"active_numerator_strength": "7.5"
}Related drugs
Other records sharing ATC code B01AX05.
Access this data programmatically
Query FONDAPARINUX SODIUM and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.